COVID-19: Pháp chuẩn bị thử nghiệm lâm sàng 3 loại thuốc điều trị

Ngày 11/3, Bộ Nghiên cứu Pháp cho biết nước này sẽ bắt đầu chiến dịch thử nghiệm lâm sàng 3 loại thuốc trị bệnh COVID-19 mang tên Discovery vào cuối tuần này hoặc đầu tuần sau. Tổng cộng sẽ có 800 bệnh nhân Pháp bị nhiễm virus SARS-CoV-2 tham gia chương trình thử nghiệm này. Họ được chia thành 4 nhóm.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh